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Ohno K, Kuno A, Murase H, Muratsubaki S, Miki T, Tanno M,
Yano T, Ishikawa S, Yamashita T, Miura T. Diabetes increases the
susceptibility to acute kidney injury after myocardial infarction
through augmented activation of renal Toll-like receptors in rats. Am
J Physiol Heart Circ Physiol 313: H1130–H1142, 2017. First pub-
lished August 19, 2017; doi:10.1152/ajpheart.00205.2017.—Acute
kidney injury (AKI) after acute myocardial infarction (MI) worsens the
prognosis of MI patients. Although type 2 diabetes mellitus (DM) is a
major risk factor of AKI after MI, the underlying mechanism remains
unclear. Here, we examined the roles of renal Toll-like receptors (TLRs)
in the impact of DM on AKI after MI. MI was induced by coronary artery
ligation in Otsuka-Long-Evans-Tokushima fatty (OLETF) rats, a rat DM
model, and Long-Evans-Tokushima-Otsuka (LETO) rats, nondiabetic
controls. Sham-operated rats served as no-MI controls. Renal mRNA
levels of TLR2 and myeloid differentiation factor 88 (MyD88) were
significantly higher in sham-operated OLETF rats than in sham-
operated LETO rats, although levels of TLR1, TLR3, and TLR4 were
similar. At 12 h after MI, protein levels of kidney injury molecule-1
(KIM-1) and neutrophil gelatinase-associated lipocalin (NGAL) in the
kidney were elevated by 5.3- and 4.0-fold, respectively, and their
mRNA levels were increased in OLETF but not LETO rats. The
increased KIM-1 and NGAL expression levels after MI in the OLETF
kidney were associated with upregulated expression of TLR1, TLR2,
TLR4, MyD88, IL-6, TNF-, chemokine (C-C motif) ligand 2, and
transforming growth factor-1 and also with activation of p38 MAPK,
JNK, and NF-B. Cu-CPT22, a TLR1/TLR2 antagonist, administered
before MI significantly suppressed MI-induced upregulation of
KIM-1, TLR2, TLR4, MyD88, and chemokine (C-C motif) ligand 2
levels and activation of NF-B, whereas NGAL levels and IL-6 and
TNF- expression levels were unchanged. The results suggest that
DM increases the susceptibility to AKI after acute MI by augmented
activation of renal TLRs and that TLR1/TLR2-mediated signaling
mediates KIM-1 upregulation after MI.
NEW & NOTEWORTHY This is the first report to demonstrate the
involvement of Toll-like recpetors (TLRs) in diabetes-induced sus-
ceptibility to acute kidney injury after acute myocardial infarction. We
propose that the TLR1/TLR2 heterodimer may be a new therapeutic
target for the prevention of acute kidney injury in diabetic patients.
diabetes; acute kidney injury; myocardial infarction; Toll-like recep-
tor; cardiorenal syndrome
INTRODUCTION
The physiological functions of the heart and kidney are
closely interconnected, and cardiac and renal diseases often
coexist. Such a pathophysiological interaction is called car-
diorenal syndrome. Type 1 cardiorenal syndrome, as proposed
by Ronco et al. (51), is characterized by acute kidney injury
(AKI) due to rapid worsening of cardiac function. Indeed, AKI
often develops in patients with acute myocardial infarction
(MI), and the incidence ranges from 10% to 20% (20, 22, 34,
48). Importantly, AKI is strongly associated with short-term
(20) and long-term (22, 34, 48) mortality in patients with MI,
and even “subclinical” AKI has been shown to have a signif-
icant impact on clinical outcomes (23, 47). Although those
studies have shown that diabetes mellitus (DM) is an indepen-
dent risk factor for the development of AKI in patients with MI
(20, 22, 34, 48), the precise mechanism by which DM increases
the renal susceptibility to AKI is not understood.
Toll-like receptors (TLRs) are pattern recognition receptors
that initiate and regulate the innate immune response (2).
Binding of exogenous microbial components to TLRs triggers
an intracellular signaling cascade. All TLRs, except for TLR3,
share myeloid differentiation factor 88 (MyD88) as a common
adaptor protein to activate various signaling molecules, such as
NF-B and MAPKs, inducing inflammation via inflammatory
gene expression (32). TLRs also sense endogenous danger
signals, known as damage-associated molecular patterns
(DAMPs), released from damaged tissues or dead cells. In the
kidney, various types of cells, including podocytes and epithe-
lial tubular cells, express TLRs (66), and recent studies using
animal models have suggested that TLRs expressed in renal
cells play critical roles in the development of AKI induced by
renal ischemia-reperfusion (11, 37, 49, 54, 62) and by sepsis
(8). In addition, it has been reported that TLR expression in the
glomerulus and renal tubules is upregulated in animal models
of DM and in patients with DM (19, 30, 38, 40, 41, 52, 60).
The involvement of TLRs in the development of diabetic
nephropathy is also suggested by the findings that gene knock-
out of TLR2 (16) or TLR4 (40, 41) and treatment with TLR4
antagonists (9, 39) attenuated nephropathy in diabetic mice.
In the present study, we hypothesized that DM increases the
susceptibility to AKI after MI via augmented activation of
TLRs. The rationale for the hypothesis was threefold. First, in
the setting of MI, endogenous intracellular contents of necrotic
cells are released into the circulation as DAMPs, such as
high-mobility group protein 1 (HMGB1) (35), nucleic acids (6,
10), and nucleosomes (27), which can cause kidney injury (3,
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49, 58, 63). Second, increased expression of TLRs has been
demonstrated in renal tubular cells, a major site of cell injury
in AKI, in the diabetic kidney (19, 30, 38, 40, 41, 43, 52, 60).
Third, a recent experimental study (13) has shown that AKI
occurring after MI was associated with increased NF-B ac-
tivity and the inflammatory response in the kidney, suggesting
a role of renal inflammation in MI-induced AKI. To test our
hypothesis, we compared renal damage and responses of TLR-
mediated signaling after MI in Otsuka-Long-Evans-Tokushima
fatty (OLETF) rats, a rat model of obese type 2 DM, and
Long-Evans-Tokushima-Otsuka (LETO) rats, nondiabetic con-
trols, and we also assessed the effects of pharmacological
blockade of TLRs on AKI. OLETF rats at the age of 25–30 wk
were selected as DM model rats because baseline ventricular
systolic function and renal blood flow level (33, 57) and
myocardial infarct size after permanent coronary artery occlu-
sion are similar to those in LETO rats (44, 57).
MATERIALS AND METHODS
Animals and experimental protocol. This study was conducted in
strict accordance with the National Institutes of Health Guide for the
Care and Use of Laboratory Animals (2011) and was approved by the
Animal Use Committee of Sapporo Medical University.
Male LETO and OLETF rats were purchased from Sankyo Labo
Service (Tokyo, Japan). LETO and OLETF rats at the age of 25–30
wk were used in all experiments. Rats were prepared for the induction
of MI as in our previous studies (44, 57). In brief, rats were anesthe-
tized with pentobarbital sodium (40 mg/kg ip). The level of anesthesia
was continuously monitored during the experiments and an additional
dose of pentobarbital was administered when necessary. Rats were
then intubated and ventilated with a rodent respirator (model 683,
Harvard Apparatus, South Natick, MA). After a left thoracotomy, a
marginal branch of the left coronary artery was permanently ligated
using a 5-0 silk thread to induce MI. The surgical wounds were
repaired, and rats were returned to their cages. All rats were allowed
ad libitum access to water but restricted from food for 12 h. Using
separate groups of OLETF rats, we tested the effect of TLR blockade
on renal injury. Either Cu-CPT22 (3 mg/kg, Tocris Bioscience), a
selective TLR1/TLR2 inhibitor (12, 31), or a vehicle (75% DMSO
plus 25% distilled water, 4 ml/kg) was administered to OLETF rats
intraperitoneally 1 min before the induction of MI.
Sampling of blood, kidney tissues, and the myocardium in the
noninfarct region was performed at 12 h after MI because our
previous studies (44, 57) have showed that approximately two-thirds
of OLETF rats die during a period of 48 h after MI due to heart failure.
Rats were reanesthetized and ventilated, and the level of anesthesia,
blood pressure, and heart rate were monitored as described above.
Blood samples were taken via a catheter placed in the carotid artery.
The abdomen was then opened, and the kidneys were excised imme-
diately after occlusion of renal arteries and veins for immersion in
iced-cold saline. One kidney was quickly frozen in liquid nitrogen and
stored at 80°C until use for biochemical analyses, and the other
kidney was fixed with 10% formaldehyde for histology. The chest was
reopened, and the heart was excised and immediately immersed in
ice-cold saline. The myocardium in the noninfarcted region was
quickly excised, frozen in liquid nitrogen, and stored at 80°C until
used for analyses.
Histological analyses. Periodic acid-Schiff staining was performed
to examine renal tissue abnormality. For immunohistochemistry,
formaldehyde-fixed paraffin sections (3 m) were stained using pri-
mary antibodies against kidney injury molecule-1 (KIM-1; AF3689,
R&D Systems, 1:20), neutrophil gelatinase-associated lipocalin
(NGAL; 1:100, sc-50531, Santa Cruz Biotechnology), NF-B p65
(1:400, no. 8242, Cell Signaling Technology), and cleaved caspase-3
(1:50, no. 9664, Cell Signaling Technology). The KIM-1-, NGAL-,
and cleaved caspase-3-positive area and the percentage of p65-posi-
tive nuclei were determined in 10 randomly selected fields from 6
kidneys in each group. The glomerular area was excluded for analyses
of KIM-1 and NGAL. Glomerular cells were not included for analysis
of the percentage of p65-positive nuclei.
In a series of experiments in which the effects of Cu-CPT22 on
AKI in OLETF rats were examined, myocardial infarct size was
determined by triphenyltetrazolium staining as previously reported
(29). Frozen hearts were sliced into 1.5-mm-thick sections and stained
with triphenyltetrazolium chloride. Areas of infarct and regions at risk
were determined using ImageJ software (National Institutes of
Health). Their volumes were obtained by multiplying each area by 1.5
mm, i.e., the thickness of the heart slice.
mRNA quantification. Total RNA was isolated from frozen tissues
using an RNeasy Fibrous Tissue Mini Kit (Qiagen, Valencia, CA).
First-strand cDNA was synthesized using a SuperScript VILO cDNA
Synthesis Kit (Life Technologies). DNA amplification was performed
in ABI PRISM7500 (Life Technologies) using Taqman Universal
PCR Master Mix (Applied Biosystems). The Taqman gene expression
assays used in this study were as follows: brain (B-type) natriuretic
peptide (BNP; Rn00676450_g1), KIM-1 (Rn00597703_m1), NGAL
(Rn00590612_m1), TLR1 (Rn04181452_s1), TLR2 (Rn02133647_
s1), TLR3 (Rn01488472_g1), TLR4 (Rn00569848_m1), TLR6
(Rn02121288_s1), MyD88 (Rn01640049_m1), IL-6 (Rn01410330_
m1), TNF- (Rn99999017_m1), IL-1 (Rn00580432_m1), transforming
growth factor-1 (TGF-; Rn01475964_m1), chemokine (C-C motif)
ligand (CCL)2 (Rn00580555_m1), CCL3 (Rn01464736_g1), and -ac-
tin (Rn00667869_m1). All assays were performed in duplicate and by
the standard curve method using serial cDNA dilution. -Actin served
as an internal control.
Immunoblot analysis. Frozen tissue samples were homogenized in
ice-cold buffer (CelLytic MT Cell Lysis Reagent, Sigma-Aldrich)
including protease and phosphatase inhibitor cocktails (Nacalai
Tesque, Kyoto, Japan). The homogenate was centrifuged at 15,000 g
for 15 min at 4°C to obtain the supernatant. Equal amounts of protein
were analyzed by immunoblot assays using anti-phospho-Ser157 va-
sodilator-stimulated phosphoprotein (VASP; 1:1,000, no. 3111, Cell
Signaling Technology), anti-phospho-p38 MAPK (1:1,000, no. 9211,
Cell Signaling Technology), anti-p38 MAPK (1:1,000, no. 9212, Cell
Signaling Technology), anti-phospho-JNK (1:1,000, no. 9251, Cell
Signaling Technology), anti-JNK (1:1,000, no. 9252, Cell Signaling
Technology), and anti-vinculin (1:5,000, V9131, Sigma-Aldrich).
Intensities of individual bands were quantified using ImageJ software
(National Institutes of Health).
Urine KIM-1 measurement. Urine was aspirated from the bladder
12 h after MI in OLETF rats pretreated with vehicle or Cu-CPT22.
Urine levels of KIM-1 were measured by ELISA (RKM100, R&D
Systems) in accordance with the manufacturer’s instructions.
Serum troponin I measurement. Serum troponin I levels were
measured by ELISA (CTNI-2-HS, Life Diagnostics) in accordance
with the manufacturer’s instructions.
Statistical analyses. Data are presented as means  SE. Statistical
significance was determined using unpaired Student’s two-tailed t-test
for two data sets. Two-way ANOVA and Student-Newman-Keuls
post hoc test were used to analyze differences in data between sham
and MI in LETO and OLETF rats. A 2-test was performed to test
differences in mortality after MI between LETO and OLETF rats. For
all tests, P 	 0.05 was considered statistically significant. All analyses
were performed with SigmaStat (Systat, San Jose, CA).
RESULTS
AKI after MI in OLETF rats. LETO and OLETF rats were
assigned to sham surgery or coronary occlusion; 9 LETO rats
and 10 OLETF rats underwent sham surgery and 11 LETO rats
and 12 OLETF rats received coronary artery ligation. None of
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the 9 rats in the sham-operated LETO group, 1 of the 10 rats in
the sham-operated OLETF group, 2 of the 11 rats in the LETO
with MI group, and 3 of the rats in the 12 OLETF with MI
group died within 12 h after surgery. The mortality rates in
LETO and OLETF rats at 12 h after MI were comparable to
those in our previous studies (44, 57), and there was no
statistical difference between post-MI mortalities in LETO and
OLETF rats.
Body weight was heavier and blood glucose and serum
insulin levels at 12 h after surgery were significantly higher
in OLETF rats than in LETO rats (Table 1). Although blood
urea nitrogen levels were comparable in LETO and OLETF
rats, serum creatinine level was lower in OLETF rats than in
LETO rats (Table 1) as in previous studies (5, 33, 45),
reflecting glomerular hyperfiltration associated with DM in
this model (33). MI did not affect these indexes of glomer-
ular function in LETO and OLETF rats. Heart rate was
lower in OLETF rats than in LETO rats, as previously
reported (36, 44, 57). In contrast to OLETF rats in our
previous studies (36, 44, 57), the averages of systolic and
diastolic blood pressures in OLETF rats were rather lower
than those in LETO rats (Table 1), presumably due to larger
doses of pentobarbital administered to some of the OLETF
rats in this study.
Although we did not measure myocardial infarct size in the
present study except for in Cu-CPT22 experiments (below), we
previously confirmed that permanent occlusion of the coronary
artery results in comparable sizes of myocardial infarcts in
LETO and OLETF rats (44, 57). In the present study, we
measured the BNP mRNA level in the myocardium remote
from the infarcted region 12 h after MI to compare ventricular
loading conditions after MI in LETO and OLETF rats. As
shown in Fig. 1A, there was no significant difference between
tissue BNP mRNA levels in sham-operated LETO and OLETF
rats, and BNP mRNA levels were similarly increased in LETO
and OLETF rats with MI. In addition, we assessed phosphor-
ylation levels of VASP at Ser157, a PKA phosphorylation site,
in the noninfarcted myocardium as an index of adrenergic
activity. Phospho-Ser157 VASP levels at 12 h after MI were
similar in LETO and OLETF rats (Fig. 1, B and C). These
findings suggest that ventricular loading and adrenergic activ-
Table 1. Body weight, blood examinations, and hemodynamic parameters in LETO and OLETF rats at 12 h after surgery
LETO Rats OLETF Rats
Sham MI Sham MI
Body weight, g 537  13 507  24 617  23* 636  18†
Blood glucose, mg/dl 140  10 158  10 267  32* 326  48†
Serum insulin, ng/ml 5.4  1.3 6.8  1.3 18.7  2.7* 27.8  5.1†
Serum creatinine, mg/dl 0.72  0.04 0.58  0.07 0.49  0.07* 0.43  0.04†
Blood urea nitrogen, mg/dl 15.4  2.0 23.3  3.4 20.4  1.8 24.8  5.1
Heart rate, beat/min 413  12 396  11 342  15* 321  10†
Systolic blood pressure, mmHg 123  5 102  7 97  9* 82  7
Diastolic blood pressure, mmHg 91  5 79  7 68  9* 55  7†
Values are means  SE; n 
 6–9 in each group. OLETF rats, Otsuka-Long-Evans-Tokushima fatty rats; LETO rats, Long-Evans-Tokushima-Otsuka rats; MI,




































Fig. 1. Level of brain (B-type) natriuretic peptide (BNP) mRNA in the noninfarct myocardium in Long-Evans-Tokushima-Otsuka (LETO) and Otsuka-Long-
Evans-Tokushima fatty (OLETF) rats. A: quantification of BNP mRNA levels normalized to -actin in the noninfarcted myocardium sampled 12 h after surgery.
n 
 5–9 in each group. *P 	 0.05. B: representative immunoblots for phosphorylated (p-)vasodilator-stimulated phosphoprotein (VASP) at Ser157 and vinculin
in the noninfarcted myocardium sampled 12 h after surgery. C: summary data of p-VASP levels normalized to vinculin. n 
 6 in each group. AU, arbitrary units;
MI, myocardial infarction.
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ity in response to heart failure were comparable in LETO and
OLETF rats at least at the time of 12 h after MI.
Periodic acid-Schiff staining in the kidney section did not
show detectable abnormalities in tubular cells, such as loss of
the brush border, tubular dilation, cast formation, and cell lysis,
in LETO and OLETF rats regardless of MI (Fig. 2A), although
sizes of glomeruli were larger in OLETF rats, as previously
reported (45). To analyze apoptosis in tubular cells, we per-
formed immunohistochemistry for cleaved caspase-3. Cleaved
caspase 3-positive cells were barely detected in tubular cells of
sham-operated LETO and OLETF rats (Fig. 2B). An increase
in cleaved caspase-3-positive tubular cells was not observed in
either LETO or OLETF rats 12 h after MI (Fig. 2, B and C),
although apoptosis of tubular cells 3 days after MI has been
reported in Sprague-Dawley rats (13).
In immunohistochemistry for KIM-1, KIM-1 signals were
barely detected in LETO rats regardless of MI (Fig. 3, A and
B). Although urinary KIM-1 excretion has been reported to be
increased in OLETF rats at the age of 14 wk (28), the extent
of KIM-1 staining of renal tubules in sham-operated OLETF
rats was not significantly different from that in LETO rats.
However, OLETF rats with MI showed focal KIM-1-positive
areas in tubular epithelial cells, and the KIM-1-positive area
was significantly larger than that in sham-operated controls
(Fig. 3, A and B). Most KIM-1-positive cells were proximal
tubular epithelial cells, although KIM-1 has been reported to be
expressed in immune cells including T cells (50) and dendritic
cells (64). KIM-1 mRNA level in the kidney was significantly
higher in OLETF rats than in LETO rats regardless of MI (Fig.
3C). The KIM-1 mRNA level tended to be higher in OLETF
rats with MI than in sham-operated OLETF rats, but the
difference did not reach statistical significance.
NGAL expression was scarcely observed in LETO rats, and
a significant change in expression after MI was not detected.


















Fig. 2. Histological analysis of the kidney after myocardial infarction. A: representative images of periodic acid-Schiff staining in the kidney 12 h after surgery.
Scale bar 
 100 m. There was no apparent abnormal finding in tubular cells after myocardial infarction (MI) in Long-Evans-Tokushima-Otsuka (LETO) and
Otsuka-Long-Evans-Tokushima fatty (OLETF) rats. B: representative images of immunohistochemistry for cleaved caspase-3 in kidney sections from LETO and
OLETF rats 12 h after surgery. Although stained cells were barely detected, magnified images show tubular cells stained with cleaved caspase-3. Scale bar 

200 m. As a positive control, an image in the kidney subjected to 40-min renal artery occlusion followed by 24-h reperfusion (I/R) is shown. A representative
image of cleaved caspase-3-positive tubular cells was magnified. A negative control image without the primary antibody is also shown. Scale bar 
 100 m.
C: summary data of cleaved caspase-3-positive areas in kidney sections. In each group, 10 randomly selected fields from 3 kidneys were analyzed. MI, myocardial
infarction.
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Whereas the immuno-NGAL signal in sham-operated OLETF
rats was similar to that in LETO rats, the NGAL-positive area
was 3.4-fold larger in OLETF rats after MI (Fig. 4, A and B).
Although NGAL expression has been reported to be upregu-
lated in distal tubular cells and collecting duct cells by isch-
emia-reperfusion injury and sepsis-associated AKI (53, 55),
increased signals of NGAL were observed in proximal tubular
cells as well as distal tubular cells in OLETF rats after MI (Fig.
4, A and C). Consistent with the results of NGAL immunohis-
tochemistry, elevation of NGAL mRNA level by MI was
observed in OLETF rats but not in LETO rats (Fig. 4D).
Renal TLR activation by MI in OLETF rats. In sham-
operated rats, mRNA levels of TLR2 and MyD88 were signif-
icantly higher in OLETF rats than in LETO rats, although
TLR1, TLR3, TLR4, and TLR6 mRNA levels were compara-
ble in the two groups (Fig. 5A). In LETO rats, MI did not affect
mRNA levels of any TLRs or MyD88. However, TLR1, TLR2,
and MyD88 mRNA levels in OLETF rats were significantly
increased by MI, and the levels were higher than those in
LETO rats with MI. TLR4 mRNA level was also higher in
OLETF rats with MI than in LETO rats with MI. In contrast,
TLR3 and TLR6 mRNA levels were not changed by MI in
either LETO or OLETF rats.
As shown in Fig. 5B, IL-6, TNF-, IL-1, and CCL2 mRNA
levels were comparable in sham-operated LETO and OLETF
rats, whereas the TGF- mRNA level was significantly higher
in sham-operated OLETF rats. MI increased levels of IL-6,
TNF-, TGF-, and CCL2 mRNA in OLETF rats, but such
changes were not observed in LETO rats. CCL3 mRNA level
was significantly higher in sham-operated OLETF rats than in
sham-operated LETO rats, and MI increased the CCL3 mRNA
level in LETO rats but not in OLETF rats.
To confirm TLR activation in the kidney of OLETF rats after
MI, we examined phosphorylation of MAPKs, intracellular
signaling molecules downstream of TLRs. Immunoblot analy-
sis showed that phospho-p38 MAPK and phospho-JNK levels
were similar in sham-operated LETO and OLETF rats (Fig. 6,
A–C). However, MI increased phosphorylation levels of p38
MAPK and JNK significantly in OLETF rats but not in LETO
rats (Fig. 6, A–C). These findings suggest that TLR activation
LETO sham LETO MI
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Sham MI Sham MI
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Fig. 3. Analysis of kidney injury molecule-1 (KIM-1) expression in the kidney after myocardial infarction (MI). A: representative images of immunohisto-
chemistry for KIM-1 in kidney sections from Long-Evans-Tokushima-Otsuka (LETO) and Otsuka-Long-Evans-Tokushima fatty (OLETF) rats 12 h after a sham
operation or MI. KIM-1 was primarily expressed at the luminal side of tubular epithelial cells. Scale bar 
 200 m. As a positive control, an image of KIM-1
immunostaining in the kidney subjected to 40-min renal artery occlusion followed by 24-h reperfusion (I/R) is shown. A negative control image without the
primary antibody is also shown. B: summary data of KIM-1-positive areas. In each group, 10 randomly selected fields from 6 kidneys were analyzed. C:
quantification of KIM-1 mRNA levels in the kidney. n 
 9 in each group. *P 	 0.05. NS, not significant.
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was induced in the kidney by MI in OLETF rats but not in
LETO rats.
Expression of inflammatory cytokines and chemokines by
activated TLRs is mediated by activation of the transcription
factor NF-B. To assess NF-B activation after MI in the
kidney of OLETF rats, we assessed nuclear translocation of
NF-B by immunostaining of p65, a subunit of NF-B. Tubu-
lar epithelial cells were the main cells positive for nucleus-
localized p65 (Fig. 7A), and the percentage of p65 localized in
the nuclei was significantly increased in OLETF rats after MI
but not in LETO rats (Fig. 7B). The results are consistent with
increased mRNA expression of IL-6, TNF-, and CCL2,
NF-B-regulated cytokines (Fig. 5B).
Blockade of TLR1/TLR2 attenuated renal response to MI in
OLETF rats. To get an insight into the subtype of TLR
involved in MI-induced AKI in OLETF rats, we examined the
effect of a TLR antagonist in separate groups of OLETF rats.
TLR2 mainly acts as a heterodimer with either TLR1 or TLR6
(7), and expression of TLR2 in the kidney was higher in
OLETF rats without MI than in LETO rats without MI (Fig.
5A). Furthermore, MI significantly upregulated the expressions
of both TLR1 and TLR2 in OLETF rats. Thus, we chose
Cu-CPT22, a TLR1/TLR2 antagonist, to examine the relation-
ship between TLR activation and AKI. OLETF rats were
assigned to a vehicle-treated group (n 
 11) or a Cu-CPT22-
treated group (n 
 9), and one rat in each group died within 12
h after MI. Cu-CPT22 did not affect levels of blood glucose,
serum creatinine, or blood urea nitrogen 12 h after MI (Table
2). Neither heart rate nor blood pressure at 12 h after MI was
modified by Cu-CPT22 (Table 2). There was no difference in
infarct size as a percentage of the left ventricle between
vehicle- and Cu-CPT22-treated OLETF rats (24.4  2.8 vs.
22.4  0.8%). Serum troponin I levels 12 h after MI were also
comparable in the two groups (20.4  1.0 ng/ml for the vehi-
cle-treated group and 19.6  1.4 ng/ml for the Cu-CPT22-
treated group).
Immunohistochemistry for KIM-1 revealed that Cu-CPT22
significantly reduced the KIM-1-positive area in the kidney 12
A
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Fig. 4. Analysis of neutrophil gelatinase-associated lipocalin (NGAL) expression in the kidney after myocardial infarction (MI). A: representative images of
immunohistochemistry for NGAL in kidney sections from Long-Evans-Tokushima-Otsuka (LETO) and Otsuka-Long-Evans-Tokushima fatty (OLETF) rats 12
h after a sham operation or MI. NGAL was mainly expressed in tubular epithelial cells. Scale bar 
 200 m. As a positive control, an image of NGAL
immunostaining in the kidney subjected to 40-min renal artery occlusion followed by 24-h reperfusion (I/R) is shown. A negative control image without the
primary antibody is also shown. B: summary data of NGAL-positive areas. In each group, 10 randomly selected fields from 6 kidneys were analyzed. C: image
of NGAL staining in distal tubular cells (arrow) and proximal tubular cells (arrowhead) in a kidney section from an OLETF rat after MI. Scale bar 
 50 m.
D: NGAL mRNA quantification in the kidney. n 
 9 in each group. *P 	 0.05.
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h after MI (Fig. 8, A and B). The level of KIM-1 mRNA in the
kidney after MI was also significantly decreased by Cu-CPT22
(Fig. 8C). The urine KIM-1 level tended to be lower in
Cu-CPT22-treated OLETF rats than in vehicle-treated OLETF
rats (1.12  0.03 vs. 1.55  0.23 ng/ml, P 
 0.09), although
we could not determine total KIM-1 release into urine because
of the lack of data for urine flow rates. On the other hand, the
NGAL-positive area and NGAL mRNA level in the kidney
after MI were not changed by Cu-CPT22 (Fig. 8, D–F). TLR2,











































































































































































































































Fig. 5. Expression levels of Toll-like receptors (TLRs), cytokines, and chemokines in the kidney. A: gene expression of TLRs and the adaptor molecule myeloid
differentiation factor 88 (MyD88) in kidneys from Long-Evans-Tokushima-Otsuka (LETO) and Otsuka-Long-Evans-Tokushima fatty (OLETF) rats 12 h after
a sham operation or myocardial infarction (MI). B: expression levels of cytokines and chemokines in the kidney. n 
 9 in each group. IL, interleukin; TNF-,




































































Fig. 6. MAPK was activated in the kidney of Otsuka-Long-Evans-Tokushima fatty (OLETF) rats after myocardial infarction (MI). A: representative immunoblots
for phosphorylated (p-)p38 MAPK, p38 MAPK, p-JNK, JNK, and vinculin in kidneys from Long-Evans-Tokushima-Otsuka (LETO) and OLETF rats 12 h after
a sham operation or MI. B and C: summary data of p-p38 MAPK (B) and p-JNK1/2 (C) normalized by their respective total protein levels. n 
 4 in each group.
AU, arbitrary units. *P 	 0.05.
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by Cu-CPT22, although TLR1, TLR3, and TLR6 levels were
unchanged (Fig. 9A). Cu-CPT22 significantly reduced mRNA
levels of IL-1 and CCL2, whereas its effect on IL-6 and
TNF- levels were statistically insignificant (Fig. 9B). Phos-
pho-p38 MAPK level was significantly reduced by Cu-CPT22,
indicating blockade of TLR signaling (Fig. 10, A and C),
although the phospho-JNK level was unchanged (Fig. 10, B
and C). The percentage of p65-positive nuclei after MI was
also significantly reduced by Cu-CPT22 (Fig. 10, D and E).
DISCUSSION
In the present model of MI-induced AKI, serum creatinine
and blood urea nitrogen levels were not significantly increased,
but KIM-1 and NGAL protein expression levels were increased
by 5.3- and 4.0-fold, respectively, in the kidney of OLETF rats.
This phenotype of renal injury is consistent with “subclinical”
AKI in patients. Although subclinical AKI is a modest injury
compared with clinical AKI, which is defined by a significant
elevation of serum creatinine level and/or reduction of urine
output, accumulating evidence indicates that subclinical AKI
has a significant impact on clinical outcomes (23, 47). Re-
cently, by analyses of multicenter pooled data for patients
admitted to intensive care units, Haase et al. (23) demonstrated
that subclinical AKI, defined as an elevated urine or plasma
NGAL level but without elevation of the serum creatinine
level, was associated with a significant increase in renal re-
A
LETO sham LETO MI
OLETF sham OLETF MI
p65-positive nuclei
(%)











Fig. 7. Activation of NF-B in the kidney by myocardial infarction (MI) in Otsuka-Long-Evans-Tokushima fatty (OLETF) rats. A: representative images of
immunohistochemistry for the NF-B subunit p65 in kidney sections from Long-Evans-Tokushima-Otsuka (LETO) and OLETF rats 12 h after a sham operation
or MI. Most cells with nuclear p65 were tubular epithelial cells. As a positive control, an image of p65 immunostaining in the kidney subjected to 40-min renal
artery occlusion followed by 24-h reperfusion (I/R) is shown. A negative control image without the primary antibody is also shown. Scale bar 
 100 m. B:
summary data of the percentage of p65-positive nuclei. In each group, 10 randomly selected fields from 6 kidneys were analyzed. Nuclear p65 was significantly
increased by MI in OLETF rats but not in LETO rats. *P 	 0.05.
Table 2. Effects of pretreatment with Cu-CPT22 on body
weight, serum biochemistry, and hemodynamic parameters
at 12 h after myocardial infarction in OLETF rats
Vehicle Cu-CPT22
Body weight, g 652  14 673  8
Blood glucose, mg/dl 428  30 376  19
Serum creatinine, mg/dl 0.32  0.02 0.32  0.03
Blood urea nitrogen, mg/dl 20.6  1.2 22.3  1.7
Heart rate, beats/min 272  12 276  10
Systolic blood pressure, mmHg 115  2 116  3
Diastolic blood pressure, mmHg 86  3 81  4
Values are means  SE; n 
 8–10 in each group. OLETF, Otsuka-Long-
Evans-Tokushima fatty rats.
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placement therapy and in-hospital mortality compared with
those in patients who were NGAL negative and did not have
elevation in serum creatinine. A study by Nickolas et al. (47)
showed that the risk of adverse clinical outcome was increased
in patients with elevated level of urinary NGAL or KIM-1,
even if the serum creatinine level was normal at admission.
These clinical observations suggest that the present model of

























































Fig. 8. Effects of Cu-CPT22 on kidney injury after myocardial infarction (MI) in Otsuka-Long-Evans-Tokushima fatty (OLETF) rats. A: representative images
of immunohistochemistry for kidney injury molecule-1 (KIM-1) in kidney sections from OLETF rats 12 h after MI pretreated with either a vehicle or Cu-CPT22.
Scale bar 
 200 m. B: summary data of KIM-1-positive areas. In each group, 10 randomly selected fields from 5 kidneys were analyzed. C: quantification of
KIM-1 mRNA levels in kidneys from vehicle- and Cu-CPT22-treated OLETF rats. n 
 6. D: representative images of immunohistochemistry for neutrophil
gelatinase-associated lipocalin (NGAL) in kidney sections. Scale bar 
 200 m. E: summary data of NGAL-positive areas. In each group, 10 randomly selected
fields from 5 kidneys were analyzed. Cu-CPT22 did not affect NGAL-positive areas. F: NGAL mRNA quantification. n 

















































































Fig. 9. Effects of pretreatment with Cu-CPT22 on expression levels of Toll-like receptors (TLRs), cytokines, and chemokines in the kidney of Otsuka-Long-
Evans-Tokushima fatty (OLETF) rats after myocardial infarction (MI). A: gene expression of TLRs and the adaptor molecule myeloid differentiation factor 88
(MyD88) in the kidney from OLETF rats after MI pretreated with either vehicle or Cu-CPT22. B: expression levels of cytokines and chemokines in the kidney.
n 
 8–10 in each group. IL, interleukin; TNF-, tumor necrosis factor-; CCL, chemokine (C-C motif) ligand. *P 	 0.05.
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OLTEF rats at the age of 25–30 wk showed an early stage of
diabetic nephropathy; the serum creatinine level was lower
(Table 1) and urinary protein was reportedly only twofold
higher in OLETF rats at that age than in LETO rats (65). In
addition, we found that baseline levels of KIM-1 and NGAL
proteins tended to be higher in OLETF rats than in LETO rats,
whereas the KIM-1 mRNA level, but not the NGAL mRNA
level, was significantly elevated in OLETF rats (Figs. 3 and 4).
Baseline levels of TLR2, MyD88, TGF-, and CCL3 mRNA
were also higher in OLETF rats (Fig. 5). It is unclear how
TLR2 is upregulated in the kidney of OLETF rats at baseline,
when NF-B activity in OLETF rats was similar to that in
LETO rats (Fig. 7). However, there are a few possible expla-
nations. First, hyperglycemia might have been involved in the
upregulation of TLR2 expression via PKC. It has been previ-
ously reported that TLR2 expression is increased in the glom-
eruli and proximal tubules in animal models of type 1 DM (39,
43, 52) and type 2 DM after the onset of hyperglycemia (19,
52). Exposure of renal tubular cells to a high level of glucose
induced TLR2 expression (39, 43), and PKC has been reported
to mediate high glucose-induced TLR2 expression in mono-
cytes (14). Second, an insulin resistance-mediated mechanism
might underlie the TLR2 upregulation. TLR2 upregulation was
reported in nonrenal tissues in human subjects with obesity and
hyperinsulinemia (1, 25), and we previously confirmed by the
use of a glucose clamp that OLETF at the age of 28~30 wk
have insulin resistance (29). Another possibility is the contri-
bution of angiotensin II. Treatment with angiotensin II has
been reported to increase TLR2 expression in nonrenal cells
(61). The level of TGF- expression, which is stimulated by
angiotensin II, was significantly higher in OLETF rats than in
LETO rats at baseline (Fig. 5B). Nevertheless, the present
findings are consistent with the findings that diabetic nephrop-
athy is associated with local release of proinflammatory cyto-
kines, inflammatory reactions, and upregulated TGF- signal-
ing (21, 59).
MI further increased the expression levels of TLR2 and
MyD88 as well as TLR4 and proinflammatory cytokines and
chemokines in OLETF rats. These MI-induced changes in
OLETF rats were associated with activation of p38 MAPK,
JNK1/2, and NF-B, all of which are intracellular signals
downstream of TLRs (Figs. 5–7). In contrast, MI did not
induce significant upregulation of KIM-1, NGAL, or TLR
























































Fig. 10. Pretreatment with Cu-CPT22 blocked activity of p38 MAPK and NF-B in the kidney of Otsuka-Long-Evans-Tokushima fatty (OLETF) rats after
myocardial infarction (MI). Representative immunoblots for phosphorylated (p-)p38 MAPK and p38 MAPK (A) and p-JNK, JNK, and vinculin (B) in kidneys
from vehicle- and Cu-CPT22-treated OLETF rats after MI. C: summary data of p-p38 MAPK and p-JNK normalized by their respective total protein levels. n 

8–10 in each group. AU, arbitrary units. *P 	 0.05. D: representative images of immunohistochemistry for the NF-B subunit p65 in kidney sections from
OLETF rats after MI pretreated with vehicle or Cu-CPT22. Scale bar 
 100 m. E: summary data of the percentage of p65-positive nuclei. In each group, 10
randomly selected fields from 5 kidneys were analyzed. Nuclear p65 was significantly reduced by Cu-CPT22. *P 	 0.05.
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the kidney to MI in OLETF and LETO rats are unlikely to be
explained by different infarct sizes or by different levels of
heart failure after MI; our previous studies have confirmed that
myocardial infarct sizes after permanent coronary artery oc-
clusion are comparable in LETO and OLETF rats (44, 57), and
the levels of tissue BNP expression and VASP phosphorylation
at Ser157 after MI were similar in OLETF and LETO rats (Fig.
1). Taken together, these findings suggest that even an early
stage of diabetic nephropathy is associated with significantly
increased susceptibility to MI-induced AKI due to modified
response of renal TLR-mediated inflammatory signaling.
Activation of NF-B is known to promote TLR upregulation
(4, 18, 46). MI induced activation of renal NF-B and in-
creased mRNA expression of TLR1, TLR2, and TLR4 (Figs. 5
and 7), and Cu-CPT22 significantly suppressed MI-induced
expression of TLR2 and TLR4 (Fig. 9A) as well as nuclear
translocation of NF-B (Fig. 10, C and D) in the kidney. Thus,
upregulation of TLR2 and TLR4 by MI in OLETF rats is likely
to be due to TLR1/TLR2-mediated NF-B activation.
Interestingly, responses of KIM-1 and NGAL expression to
MI were different in OLETF rats. Both NGAL mRNA and
protein levels were significantly increased after MI. However,
a 5.3-fold increase in KIM-1 protein after MI was accompanied
by a small and statistically insignificant change in the KIM-1
mRNA level, suggesting involvement of modified mRNA
translation. In addition, the effects of Cu-CPT22, a TLR1/
TLR2 antagonist, on KIM-1 and NGAL were different. Cu-
CPT22 significantly suppressed upregulation of KIM-1 protein
expression as well as activation of p38MAPK-NF-B signaling
and upregulation of IL-1 and CCL2 expression in the kidney
after MI, although NGAL upregulation was unaffected by
Cu-CPT22. TLR2 acts as a heterodimer with either TLR1 or
TLR6, and distinct ligands can be recognized by TLR1/TLR2
and TLR2/TLR6 (7). TLR6 expression was not changed after
MI regardless of Cu-CPT22 pretreatment. Taken together, the
alterations of cytokines and KIM-1 caused by Cu-CPT22
suggest that activation of the TLR1/TLR2 complex mediates
IL-1- and CCL2-mediated injury and KIM-1 expression in
the kidney by MI.
In contrast to the change in KIM-1, the increase in NGAL
protein as well as activation of JNK1/2 and upregulation of
IL-6 and TNF- expression after MI in OLETF rats were not
significantly suppressed by pretreatment with Cu-CPT22.
These findings indicate possible involvement of TLRs other
than TLR1/TLR2 and/or TLR-independent mechanisms. TLR4
is implicated in the development of renal tubular cell injury and
release of proinflammatory cytokines, including IL-6 and
TNF-, by ischemia-reperfusion (62) and by endotoxin (17).
We attempted to examine the effect of an antagonist of TLR4,
TAK-242 (3 mg/kg ip), on NGAL expression. Unfortunately,
however, TAK-242 turned out to be unsuitable in the present
model of diabetes because it increased mortality within 12 h
after MI without significant inhibition of TLR-mediated sig-
naling (data not shown). Interestingly, the expression of TLR4
mRNA was suppressed by Cu-CPT22 without significant
changes in mRNA levels of IL-6 and TNF-, suggesting that
upregulation of the two proinflammatory cytokines in OLETF
rats was achieved by a TLR4-independent mechanism. Such a
TLR-independent mechanism remains unclear, but hypergly-
cemia-induced metabolic derangement in tubular cells and
ischemia due to impaired autoregulation of renal blood flow are
possibilities (26, 59).
There are limitations in this study. First, whether increased
renal susceptibility to MI-induced AKI in OLETF rats is due to
hyperglycemia has not been clarified. However, preliminary
findings in our on-going project suggest that control of hyper-
glycemia attenuates upregulation of TLRs in the kidney of
OLETF rats. Second, TLR ligands that are responsible for
activation of TLR-NF-kB signaling remain unclear, although
HMGB1 and other DAMPs are known to be released from the
infarcted myocardium into circulation. Third, changes in the
biomarkers were assessed only at one time point, i.e., 12 h after
MI and time courses of alteration of AKI biomarkers in the
kidney after MI could not be examined. The high mortality
(i.e., ~70%) of OLETF rats during a period of 12–24 h after MI
(44, 57) precludes tissue samplings at 24 h and later time points
after MI in OLETF rats without selection bias in data. Thus, we
could not totally exclude the possibility that the effect of
Cu-CPT22 on NGAL expression and relevant molecules could
have been detected later than 12 h after MI since the time to
reach the peak for KIM-1 and NGAL after insult is not
necessarily the same (15, 24, 42, 56). Finally, the impact of
AKI after MI in the present study on long-term function of
diabetic kidneys has not been characterized. A recent study
(13) has shown that MI did not increase serum creatinine level
at 3 days after MI but induced macrophage-mediated intersti-
tial inflammation in the kidney and proteinuria 4 wk later in
nondiabetic rats. Whether enhanced upregulation of inflamma-
tory cytokines by DM after MI worsens proteinuria or other
indexes of chronic renal disease several months after MI
remains to be elucidated in future projects.
In conclusion, increased susceptibility to AKI after MI in a
rat model of type 2 DM was associated with augmented
activation of TLRs and NF-B-mediated inflammatory signal-
ing in the kidney. Distinct TLRs were suggested to be involved
in MI-induced upregulation of KIM-1 and NGAL, although the
possibility of contribution of TLR-independent mechanisms
cannot be excluded. The mechanism of DM-induced augmen-
tation of TLR activation in the kidney after MI remains to be
elucidated.
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